Real‐world data on the efficacy and safety of immune‐checkpoint inhibitors in elderly patients with non‐small cell lung cancer

D Morinaga, H Asahina, S Ito, O Honjo… - Cancer …, 2023 - Wiley Online Library
Purpose Immune‐checkpoint inhibitors (ICIs) are effective against advanced non‐small cell
lung cancer (NSCLC). However, whether the efficacy and safety of ICI treatment in elderly …

Notch pathway regulates osimertinib drug‐tolerant persistence in EGFR‐mutated non–small‐cell lung cancer

…, M Furuta, T Shoji, K Tsuji, D Morinaga… - Cancer …, 2023 - Wiley Online Library
Osimertinib is a third‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase
inhibitor (TKI) that has shown marked antitumor activity in patients with EGFR‐mutated non–…

Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary …

Y Takashima, N Shinagawa, D Morinaga… - BMC Pulmonary …, 2022 - Springer
Background Endobronchial ultrasound (EBUS)-guided transbronchial biopsy (TBB) facilitates
the diagnosis of various respiratory diseases. The safety of performing EBUS-guided TBB …

Characteristics of COVID-19 patients admitted into two hospitals in Sapporo, Japan: analyses and insights from two outbreak waves

…, H Chiba, K Kuronuma, M Amishima, D Morinaga… - Respiratory …, 2021 - Elsevier
Background Coronavirus disease (COVID-19) emerged in January 2020 in Sapporo city,
and the outbreak has shown two peaks. Methods A total of 260 COVID-19 patients were …

The hotei mutation of medaka in the anti-Müllerian hormone receptor causes the dysregulation of germ cell and sexual development

C Morinaga, D Saito, S Nakamura… - Proceedings of the …, 2007 - National Acad Sciences
We previously performed mutant screens in the medaka for defects in gonadal development
and identified a mutant of interest in this regard, which was designated as hotei (hot). This …

Plasma ANGPTL8 levels and risk for secondary cardiovascular events in Japanese patients with stable coronary artery disease receiving statin therapy

J Morinaga, K Kashiwabara, D Torigoe… - … , and vascular biology, 2023 - Am Heart Assoc
BACKGROUND: The ability to predict secondary cardiovascular events could improve health
of patients undergoing statin treatment. Circulating ANGPTL8 (angiopoietin-like protein 8) …

Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer

…, Y Takashima, T Shoji, H Takahashi, S Ito, D Morinaga… - Cell Cycle, 2023 - Taylor & Francis
Mitotic slippage, which enables cancer cells to bypass cell death by transitioning from
mitosis to the G1 phase without undergoing normal cytokinesis, is one likely mechanism of …

A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non …

…, Y Kawashima, R Saito, D Morinaga… - Oncology …, 2023 - spandidos-publications.com
The present multicenter study was performed to compare the efficacy of epidermal growth
factor receptor‑tyrosine kinase inhibitor (EGFR‑TKI) monotherapy with that of combined EGFR‑…

Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model

Y Morinaga, Y Take, D Sasaki, K Ota, N Kaku, N Uno… - PLoS …, 2019 - journals.plos.org
The alteration of the microbial community in the upper respiratory tract (URT) can contribute
to the colonization and invasion of respiratory pathogens. However, there are no studies …

Delayed-onset organizing pneumonia emerging after recovery from coronavirus disease 2019: A report of three cases diagnosed using transbronchial cryobiopsy and …

…, M Matsumoto, H Horii, K Sato, D Morinaga… - Internal …, 2022 - jstage.jst.go.jp
We present three cases with an atypical clinical course of organizing pneumonia (OP)
secondary to coronavirus disease 2019 (COVID-19). Three patients were discharged with …